Therapeutic approach for COVID-19: The power of herbal medicine

Detalhes bibliográficos
Autor(a) principal: Abreu, Danilo José Machado de
Data de Publicação: 2020
Outros Autores: Barros, Hanna Elisia Araújo de, Natarelli, Caio Vinicius Lima, Zanzini, Alice Pereira, Boas, Eduardo Valério de Barros Vilas, Piccoli, Roberta Hilsdorf, Carvalho, Elisângela Elena Nunes
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/8907
Resumo: The objective of this work was to evaluate whether medicinal plants as active ingredients of herbal, homeopathic and floral medicines marketed in Brazil, had potential use as a therapeutic strategy for prevention, treatment and cure for COVID-19. This study took into account products marketed and regulated by Brazilian legislation with claims such as: immunomodulators, antivirals and improvement of symptoms related to respiratory system deficiency, which were calculated the absolute (n) and relative (%) frequencies. In addition, PubMed®, Web of Science® and SciVerse Scopus® databases were used to search the literature in order to obtain the scientific claims of plants found in the formulations of the evaluated products, taking into account the typical symptoms of COVID-19. 113 products were found, of which 65% were herbal medicines, 27% homeopathic medicines and 7% floral. There were 13 medicinal plants with an absolute frequency ≥ 5, in which scientific evidence was found regarding their medicinal use, as a complementary therapy in the treatment of symptoms related to COVID-19.
id UNIFEI_315223720a529616fbea308d8c1cc858
oai_identifier_str oai:ojs.pkp.sfu.ca:article/8907
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Therapeutic approach for COVID-19: The power of herbal medicineEnfoque terapéutico para COVID-19: El poder de la medicina herbalAbordagem terapêutica para COVID-19: O poder da medicina herbalPlantas medicinaisHomeopáticosFloraisSARS-CoV-2Tratamento complementar.Medicinal plantsHomeopathicsFloralsSARS-CoV-2Complementary treatment.Plantas medicinalesHomeopáticosFloralesSARS-CoV-2Tratamiento complementario.The objective of this work was to evaluate whether medicinal plants as active ingredients of herbal, homeopathic and floral medicines marketed in Brazil, had potential use as a therapeutic strategy for prevention, treatment and cure for COVID-19. This study took into account products marketed and regulated by Brazilian legislation with claims such as: immunomodulators, antivirals and improvement of symptoms related to respiratory system deficiency, which were calculated the absolute (n) and relative (%) frequencies. In addition, PubMed®, Web of Science® and SciVerse Scopus® databases were used to search the literature in order to obtain the scientific claims of plants found in the formulations of the evaluated products, taking into account the typical symptoms of COVID-19. 113 products were found, of which 65% were herbal medicines, 27% homeopathic medicines and 7% floral. There were 13 medicinal plants with an absolute frequency ≥ 5, in which scientific evidence was found regarding their medicinal use, as a complementary therapy in the treatment of symptoms related to COVID-19.El objetivo de este trabajo fue evaluar si las plantas medicinales como ingredientes activos de los medicamentos herbales, homeopáticos y florales comercializados en Brasil, tenían un uso potencial como estrategia terapéutica para la prevención, tratamiento y cura del COVID-19. Este estudio tomó en cuenta productos comercializados y regulados por la legislación brasileña con reclamos tales como: inmunomoduladores, antivirales y mejoría de síntomas relacionados con la deficiencia del sistema respiratorio, los cuales se calcularon las frecuencias absolutas (n) y relativas (%). Además, se utilizaron las bases de datos PubMed®, Web of Science® y SciVerse Scopus® para buscar en la literatura con el fin de obtener los reclamos científicos de las plantas que se encuentran en las formulaciones de los productos evaluados, teniendo en cuenta los síntomas típicos del COVID-19. Se encontraron 113 productos, de los cuales el 65% eran medicamentos a base de hierbas, el 27% medicamentos homeopáticos y el 7% florales. Fueron 13 plantas medicinales con una frecuencia absoluta ≥ 5, en las que se encontró evidencia científica sobre su uso medicinal, como terapia complementaria en el tratamiento de síntomas relacionados con COVID-19.O objetivo deste trabalho foi avaliar se as plantas medicinais, como princípios ativos de medicamentos fitoterápicos, homeopáticos e florais comercializados no Brasil, têm potencial uso como estratégia terapêutica para prevenção, tratamento e cura do COVID-19. Este estudo considerou produtos comercializados e regulamentados pela legislação brasileira com reivindicações como: imunomoduladores, antivirais e melhora de sintomas relacionados à deficiência do aparelho respiratório, sendo calculadas frequências absolutas (n) e relativas (%). Além disso, os bancos de dados PubMed®, Web of Science® e SciVerse Scopus® foram utilizados em busca na literatura para obter afirmações científicas das plantas encontradas nas formulações dos produtos avaliados, considerando sintomas típicos da COVID-19. Foram encontrados 113 produtos, dos quais 65% eram fitoterápicos, 27% medicamentos homeopáticos e 7% florais. Houve 13 plantas medicinais com frequência absoluta ≥ 5, nas quais foram encontradas evidências científicas quanto a seu uso medicinal como terapia complementar no tratamento dos sintomas relacionados à COVID-19.Research, Society and Development2020-10-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/890710.33448/rsd-v9i10.8907Research, Society and Development; Vol. 9 No. 10; e6789108907Research, Society and Development; Vol. 9 Núm. 10; e6789108907Research, Society and Development; v. 9 n. 10; e67891089072525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/8907/8071Copyright (c) 2020 Danilo José Machado de Abreu; Hanna Elisia Araújo de Barros; Caio Vinicius Lima Natarelli; Alice Pereira Zanzini; Eduardo Valério de Barros Vilas Boas; Roberta Hilsdorf Piccoli; Elisângela Elena Nunes Carvalhohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAbreu, Danilo José Machado deBarros, Hanna Elisia Araújo de Natarelli, Caio Vinicius Lima Zanzini, Alice Pereira Boas, Eduardo Valério de Barros Vilas Piccoli, Roberta Hilsdorf Carvalho, Elisângela Elena Nunes 2020-10-31T12:03:23Zoai:ojs.pkp.sfu.ca:article/8907Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:31:16.722859Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Therapeutic approach for COVID-19: The power of herbal medicine
Enfoque terapéutico para COVID-19: El poder de la medicina herbal
Abordagem terapêutica para COVID-19: O poder da medicina herbal
title Therapeutic approach for COVID-19: The power of herbal medicine
spellingShingle Therapeutic approach for COVID-19: The power of herbal medicine
Abreu, Danilo José Machado de
Plantas medicinais
Homeopáticos
Florais
SARS-CoV-2
Tratamento complementar.
Medicinal plants
Homeopathics
Florals
SARS-CoV-2
Complementary treatment.
Plantas medicinales
Homeopáticos
Florales
SARS-CoV-2
Tratamiento complementario.
title_short Therapeutic approach for COVID-19: The power of herbal medicine
title_full Therapeutic approach for COVID-19: The power of herbal medicine
title_fullStr Therapeutic approach for COVID-19: The power of herbal medicine
title_full_unstemmed Therapeutic approach for COVID-19: The power of herbal medicine
title_sort Therapeutic approach for COVID-19: The power of herbal medicine
author Abreu, Danilo José Machado de
author_facet Abreu, Danilo José Machado de
Barros, Hanna Elisia Araújo de
Natarelli, Caio Vinicius Lima
Zanzini, Alice Pereira
Boas, Eduardo Valério de Barros Vilas
Piccoli, Roberta Hilsdorf
Carvalho, Elisângela Elena Nunes
author_role author
author2 Barros, Hanna Elisia Araújo de
Natarelli, Caio Vinicius Lima
Zanzini, Alice Pereira
Boas, Eduardo Valério de Barros Vilas
Piccoli, Roberta Hilsdorf
Carvalho, Elisângela Elena Nunes
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Abreu, Danilo José Machado de
Barros, Hanna Elisia Araújo de
Natarelli, Caio Vinicius Lima
Zanzini, Alice Pereira
Boas, Eduardo Valério de Barros Vilas
Piccoli, Roberta Hilsdorf
Carvalho, Elisângela Elena Nunes
dc.subject.por.fl_str_mv Plantas medicinais
Homeopáticos
Florais
SARS-CoV-2
Tratamento complementar.
Medicinal plants
Homeopathics
Florals
SARS-CoV-2
Complementary treatment.
Plantas medicinales
Homeopáticos
Florales
SARS-CoV-2
Tratamiento complementario.
topic Plantas medicinais
Homeopáticos
Florais
SARS-CoV-2
Tratamento complementar.
Medicinal plants
Homeopathics
Florals
SARS-CoV-2
Complementary treatment.
Plantas medicinales
Homeopáticos
Florales
SARS-CoV-2
Tratamiento complementario.
description The objective of this work was to evaluate whether medicinal plants as active ingredients of herbal, homeopathic and floral medicines marketed in Brazil, had potential use as a therapeutic strategy for prevention, treatment and cure for COVID-19. This study took into account products marketed and regulated by Brazilian legislation with claims such as: immunomodulators, antivirals and improvement of symptoms related to respiratory system deficiency, which were calculated the absolute (n) and relative (%) frequencies. In addition, PubMed®, Web of Science® and SciVerse Scopus® databases were used to search the literature in order to obtain the scientific claims of plants found in the formulations of the evaluated products, taking into account the typical symptoms of COVID-19. 113 products were found, of which 65% were herbal medicines, 27% homeopathic medicines and 7% floral. There were 13 medicinal plants with an absolute frequency ≥ 5, in which scientific evidence was found regarding their medicinal use, as a complementary therapy in the treatment of symptoms related to COVID-19.
publishDate 2020
dc.date.none.fl_str_mv 2020-10-14
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/8907
10.33448/rsd-v9i10.8907
url https://rsdjournal.org/index.php/rsd/article/view/8907
identifier_str_mv 10.33448/rsd-v9i10.8907
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/8907/8071
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 9 No. 10; e6789108907
Research, Society and Development; Vol. 9 Núm. 10; e6789108907
Research, Society and Development; v. 9 n. 10; e6789108907
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052660830961664